CLINICAL TRIALS

Micromet is currently enrolling patients in BLAST, a pivotal study of the Company's lead product candidate blinatumomab in patients with ALL.
Learn more about this study


CAREERS AT MICROMET

Micromet looks to recruit the best and brightest in the industry.
Explore current career opportunities

RECENT NEWS

January 26, 2012
Amgen to Acquire Micromet
January 9, 2012
Micromet Signs CRADA with National Cancer Institute to Expand Development of Blinatumomab

UPCOMING EVENTS

Micromet Inc at RBC Global Healthcare Conference
February 28, 2012
Event Webcast
Micromet Inc at Roth Capital OC Growth Stock Conference
March 11, 2012
Event Webcast
© Micromet, Inc. 2010 | Privacy Notice  | Terms of Use  | Imprint  |